Adverum Biotechnologies
Gene therapy for vision
About Adverum Biotechnologies
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company focused on establishing gene therapy as a new standard of care for prevalent ocular diseases. Utilizing its proprietary intravitreal (IVT) platform, Adverum develops durable, single-administration therapies to eliminate frequent ocular injections. The company is advancing ixoberogene soroparvovec (Ixo-vec) for neovascular age-related macular degeneration. Adverum aims to transform care, preserve vision, and make a global impact.
Benefits of using Remote First Jobs
Discover Hidden Jobs
Unique jobs you won't find on other job boards.
Advanced Filters
Filter by category, benefits, seniority, and more.
Priority Job Alerts
Get timely alerts for new job openings every day.
Manage Your Job Hunt
Save jobs you like and keep a simple list of your applications.
Search remote, work from home, 100% online jobs
We help you connect with top remote-first companies.
Hiring remote talent? Post a job